The American Academy of Orthopaedic Surgeons published a new position statement, "Use of Emerging Biologic Therapies."
Here are four things to know:
1. The statement alerts physicians and patients about understanding the risks and benefits associated with stem cell and biologic treatments for musculoskeletal joint conditions.
2. Specifically, the position statement reads: "surgeons should be cognizant of the risks, benefits, regulatory status and labeled indications of the products they use."
3. AAOS also highlights "Orthopaedic Surgical Consent" and "Standards of Professionalism" guidelines in the position statement.
4. AAOS concludes the statement by calling on orthopedic surgeons and hospitals to contribute biologic treatment efficacy data to registries.